Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis

Alogliptin is one of the dipeptidyl peptidase-4 inhibitors used to treat patients with type 2 diabetes. Little is known about the nephrotoxicity associated with alogliptin, such as nephrotic syndrome or interstitial nephritis. We report a biopsy-proven rare case of minimal change nephrotic syndrome...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Kidney Med
Hlavní autoři: Shima, Hisato, Okamoto, Takuya, Tashiro, Manabu, Inoue, Tomoko, Masaki, Chiaki, Tada, Hiroaki, Takamatsu, Norimichi, Kawahara, Kazuhiko, Okada, Kazuyoshi, Doi, Toshio, Minakuchi, Jun, Kawashima, Shu
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2019
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7380391/
https://ncbi.nlm.nih.gov/pubmed/32734188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2019.03.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky